Delayed
Toronto S.E.
09:30:00 2024-04-29 am EDT
|
5-day change
|
1st Jan Change
|
0.005
CAD
|
-50.00%
|
|
-.--%
|
-.--%
|
May. 10 |
Petrichor Energy Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
|
CI
| Mar. 27 |
Avalo Therapeutics, Inc. announced that it expects to receive $115.6 million in funding from Deep Track Capital, LP, TCG Crossover Management, LLC, Commodore Capital, BVF Partners L.P., Petrichor Energy Inc., RA Capital Management, L.P.
|
CI
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
0.5293
|
0.8822
|
0.5293
|
0.3529
|
0.3529
|
0.1764
|
Enterprise Value (EV)
1 |
7.453
|
8.281
|
8.464
|
8.81
|
9.351
|
9.662
|
P/E ratio
|
-0.12
x
|
-1.79
x
|
0.19
x
|
-0.51
x
|
-0.49
x
|
-0.29
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
-
|
-
|
-
|
-
|
-
|
-
|
EV / Revenue
|
-
|
-
|
-
|
-
|
-
|
-
|
EV / EBITDA
|
-24.4
x
|
-82.3
x
|
-84.8
x
|
-
|
-
|
-
|
EV / FCF
|
6.4
x
|
-19.7
x
|
-2.26
x
|
-33.9
x
|
-41.7
x
|
-30.2
x
|
FCF Yield
|
15.6%
|
-5.06%
|
-44.3%
|
-2.95%
|
-2.4%
|
-3.31%
|
Price to Book
|
-0.04
x
|
-0.07
x
|
-0.05
x
|
-0.03
x
|
-0.03
x
|
-0.01
x
|
Nbr of stocks (in thousands)
|
35,289
|
35,289
|
35,289
|
35,289
|
35,289
|
35,289
|
Reference price
2 |
0.0150
|
0.0250
|
0.0150
|
0.0100
|
0.0100
|
0.005000
|
Announcement Date
|
4/30/19
|
6/15/20
|
4/29/21
|
4/14/22
|
4/25/23
|
4/30/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
|
-
|
-
|
-
|
-
|
-
|
-
|
EBITDA
1 |
-0.306
|
-0.1006
|
-0.0998
|
-
|
-
|
-
|
EBIT
1 |
-3.569
|
-0.1012
|
-0.1005
|
-0.0954
|
-0.0942
|
-0.1089
|
Operating Margin
|
-
|
-
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
1 |
-4.384
|
-0.4916
|
2.796
|
-0.6974
|
-0.7243
|
-0.6118
|
Net income
1 |
-4.384
|
-0.4916
|
2.796
|
-0.6974
|
-0.7243
|
-0.6118
|
Net margin
|
-
|
-
|
-
|
-
|
-
|
-
|
EPS
2 |
-0.1242
|
-0.0139
|
0.0792
|
-0.0198
|
-0.0205
|
-0.0173
|
Free Cash Flow
1 |
1.165
|
-0.4193
|
-3.747
|
-0.2598
|
-0.2243
|
-0.3196
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
4/30/19
|
6/15/20
|
4/29/21
|
4/14/22
|
4/25/23
|
4/30/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
6.92
|
7.4
|
7.93
|
8.46
|
9
|
9.49
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-22.63
x
|
-73.58
x
|
-79.49
x
|
-
|
-
|
-
|
Free Cash Flow
1 |
1.16
|
-0.42
|
-3.75
|
-0.26
|
-0.22
|
-0.32
|
ROE (net income / shareholders' equity)
|
41.6%
|
3.79%
|
-23.7%
|
6.48%
|
6.31%
|
5.04%
|
ROA (Net income/ Total Assets)
|
-132%
|
-241%
|
-324%
|
-1,703%
|
-12,604%
|
-26,586%
|
Assets
1 |
3.324
|
0.2038
|
-0.864
|
0.041
|
0.005746
|
0.002301
|
Book Value Per Share
2 |
-0.3600
|
-0.3700
|
-0.3000
|
-0.3100
|
-0.3400
|
-0.3500
|
Cash Flow per Share
2 |
0
|
0
|
0
|
0
|
0
|
0
|
Capex
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex / Sales
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
4/30/19
|
6/15/20
|
4/29/21
|
4/14/22
|
4/25/23
|
4/30/24
|
|